INTERNATIONAL ATHEROSCLEROSIS SOCIETY

Homepage - International Atherosclerosis Society

The IAS is a federation of global organizations whose basic missions are to promote the scientific understanding of atherosclerosis. The IAS is a federation of global organizations whose basic missions are to promote the scientific understanding of atherosclerosis.
232099003
IČO
1980
Založeno
WASHINGTON, DC 20006
Adresa
athero.org
Web
atherosociety
Twitter (3451)
atherosociety
Facebook (2685)
3735512
Návštěvnost

Novinky

Poslední komentáře

Incredibly excited to see the IAS fostering global collaboration on such an important issue! Together, we can drive better prevention and care for atherosclerosis! 💖🌍
detail
Just watched the Leading Insights series with Professors Santos and Watts—such valuable information on tackling persistent chylomicronemia! Thank you, IAS, for sharing these essential resources! 🙌📚
detail

Poslední diskuze

1. How can global collaborations among member organizations enhance the prevention and treatment of atherosclerosis in underserved populations?
Odpovědí: 3, Naposledy před 1 den detail
2. What innovative strategies can be implemented to address the treatment gap for patients with persistent chylomicronemia?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
INTERNATIONAL ATHEROSCLEROSIS SOCIETY logo
INTERNATIONAL ATHEROSCLEROSIS SOCIETY
+ Sledovat
65
Volunteer
4.5
Reviews
WASHINGTON
Místo
O společnosti

- G43Z -

Driving the translation of todays science into tomorrows clinical practice Fostering aglobal network for better prevention and care of atherosclerosis Featured Resources Addressing the Treatment Gap for Patients with Persistent Chylomicronemia Infographic Persistent chylomicronemia is defined by high plasma triglycerides on several occasions that is unresponsive to conventional treatments. Leading Insights A Conversation with Professors Santos and Watts Video Series Watch the first episode of IAS newLeading Insightsseries to hear Prof. Raul Santos and Prof. Gerald Watts discuss the PALISADE studys findings.

23 Vacancy More Detail